{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:14:34Z","timestamp":1793150074462,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1K22CA181274"],"award-info":[{"award-number":["1K22CA181274"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003769","name":"Foundation for Women's Wellness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007154","name":"Wake Forest University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015132","name":"Foundation for Women\u2019s Wellness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL093215"],"award-info":[{"award-number":["HL093215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL118740-01S1"],"award-info":[{"award-number":["HL118740-01S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hlc.2018.08.003","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:54:09Z","timestamp":1535874849000},"page":"1598-1605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-4942","authenticated-orcid":false,"given":"Scott P.","family":"Levick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Soto-Pantoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Gregory","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Widiapradja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Manteufel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tancia W.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3760-3812","authenticated-orcid":false,"given":"Giselle C.","family":"Mel\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2018.08.003_bib0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(02)11199-8","article-title":"Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis","volume":"360","author":"Brenner","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2018.08.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2901","article-title":"Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study","volume":"13","author":"Patnaik","year":"2011","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.hlc.2018.08.003_bib0015","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2018.08.003_bib0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1470-2045(12)70525-9","article-title":"Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial","volume":"14","author":"Mackey","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0025","first-page":"863","article-title":"Mechanisms of cardiotoxicity of cancer chemotherapeutic agents: cardiomyopathy and beyond","volume":"32","author":"Moudgil","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/clpt.2013.201","article-title":"Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity","volume":"95","author":"Vejpongsa","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hlc.2018.08.003_bib0035","article-title":"Progressive 3-month increase in LV myocardial ECV after anthracycline-based chemotherapy","author":"Mel\u00e9ndez","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.08.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004325","article-title":"Anthracycline-associated t1 mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors","volume":"9","author":"Jordan","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.08.003_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11912-016-0533-x","article-title":"Cardiac MRI: a Translational imaging tool for characterizing anthracycline-induced myocardial remodeling","volume":"18","author":"Nguyen","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.hlc.2018.08.003_bib0050","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1016\/j.ijcard.2013.07.190","article-title":"Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension","volume":"168","author":"Dehlin","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s004410050611","article-title":"Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat","volume":"284","author":"Walsh","year":"1996","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.hlc.2018.08.003_bib0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijcard.2013.11.010","article-title":"Substance P in heart failure: the good and the bad","volume":"170","author":"Dehlin","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0065","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cvr\/cvr244","article-title":"Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells","volume":"92","author":"Melendez","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hlc.2018.08.003_bib0070","doi-asserted-by":"crossref","first-page":"1959270","DOI":"10.1155\/2016\/1959270","article-title":"Substance P Receptor signaling mediates doxorubicin-induced cardiomyocyte apoptosis and triple-negative breast cancer chemoresistance","volume":"2016","author":"Robinson","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hlc.2018.08.003_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrcardio.2014.159","article-title":"Cardiac MRI: a central prognostic tool in myocardial fibrosis","volume":"12","author":"Ambale-Venkatesh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0080","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","article-title":"Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy","volume":"111","author":"Neilan","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0085","first-page":"2016","article-title":"Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging","author":"Farhad","year":"2016","journal-title":"Circ Cardiovas Imaging"},{"key":"10.1016\/j.hlc.2018.08.003_bib0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2018.08.003_bib0095","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1645\/GE-596R1.1","article-title":"Substance P is associated with heart enlargement and apoptosis in murine dilated cardiomyopathy induced by Taenia crassiceps infection","volume":"93","author":"D'Souza","year":"2007","journal-title":"J Parasitol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0105","first-page":"76","article-title":"Substance P is required for the pathogenesis of EMCV infection in mice","volume":"2","author":"Robinson","year":"2009","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.hlc.2018.08.003_bib0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/jmcc.1996.0255","article-title":"Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade","volume":"29","author":"Kramer","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0115","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/FJC.0000000000000163","article-title":"EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade","volume":"65","author":"Mak","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0019-509X.31164","article-title":"Aprepitant: a substance P antagonist for chemotherapy induced nausea and vomiting","volume":"44","author":"Girish","year":"2007","journal-title":"Indian J Cancer"},{"key":"10.1016\/j.hlc.2018.08.003_bib0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2018.08.003_bib0130","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.amjcard.2012.07.040","article-title":"Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines","volume":"110","author":"Neilan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0135","doi-asserted-by":"crossref","first-page":"62","DOI":"10.15420\/cfr.2017:3:2","article-title":"Cardiac Atrophy and heart failure in cancer","volume":"3","author":"Sweeney","year":"2017","journal-title":"Cardiac Fail Rev"},{"key":"10.1016\/j.hlc.2018.08.003_bib0140","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2018.08.003_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfu057","article-title":"An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity","volume":"140","author":"Cove-Smith","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.hlc.2018.08.003_bib0150","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.114.001180","article-title":"Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling","volume":"8","author":"Moulin","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hlc.2018.08.003_bib0155","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","article-title":"Antiemetics: American Society of Clinical Oncology clinical practice guideline update","volume":"29","author":"Basch","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hlc.2018.08.003_bib0160","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/pbc.24508","article-title":"Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients","volume":"60","author":"Dupuis","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618318560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950618318560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:00:56Z","timestamp":1761415256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950618318560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1443950618318560"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2018.08.003","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2018.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}